These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1044 related items for PubMed ID: 16160738

  • 1. Identification of osteopenic women at high risk of fracture: the OFELY study.
    Sornay-Rendu E, Munoz F, Garnero P, Duboeuf F, Delmas PD.
    J Bone Miner Res; 2005 Oct; 20(10):1813-9. PubMed ID: 16160738
    [Abstract] [Full Text] [Related]

  • 2. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study.
    Sornay-Rendu E, Munoz F, Duboeuf F, Delmas PD.
    J Bone Miner Res; 2005 Nov; 20(11):1929-35. PubMed ID: 16234965
    [Abstract] [Full Text] [Related]

  • 3. Disc space narrowing is associated with an increased vertebral fracture risk in postmenopausal women: the OFELY Study.
    Sornay-Rendu E, Munoz F, Duboeuf F, Delmas PD, OFELY Study.
    J Bone Miner Res; 2004 Dec; 19(12):1994-9. PubMed ID: 15537442
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES, Brenneman SK, Miller PD, Barrett-Connor E, Chen YT, Sherwood LM, Abbott TA.
    J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort?
    Sornay-Rendu E, Munoz F, Delmas PD, Chapurlat RD.
    J Bone Miner Res; 2010 Oct; 25(10):2101-7. PubMed ID: 20499352
    [Abstract] [Full Text] [Related]

  • 9. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
    McCloskey E, Selby P, Davies M, Robinson J, Francis RM, Adams J, Kayan K, Beneton M, Jalava T, Pylkkänen L, Kenraali J, Aropuu S, Kanis JA.
    J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
    [Abstract] [Full Text] [Related]

  • 10. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.
    Dargent-Molina P, Douchin MN, Cormier C, Meunier PJ, Bréart G, EPIDOS Study Group.
    Osteoporos Int; 2002 Jul; 13(7):593-9. PubMed ID: 12111021
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Residual lifetime risk of fractures in women and men.
    Nguyen ND, Ahlborg HG, Center JR, Eisman JA, Nguyen TV.
    J Bone Miner Res; 2007 Jun; 22(6):781-8. PubMed ID: 17352657
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Osteoporosis and fracture risk in women of different ethnic groups.
    Barrett-Connor E, Siris ES, Wehren LE, Miller PD, Abbott TA, Berger ML, Santora AC, Sherwood LM.
    J Bone Miner Res; 2005 Feb; 20(2):185-94. PubMed ID: 15647811
    [Abstract] [Full Text] [Related]

  • 16. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
    Watts NB, Geusens P, Barton IP, Felsenberg D.
    J Bone Miner Res; 2005 Dec; 20(12):2097-104. PubMed ID: 16294263
    [Abstract] [Full Text] [Related]

  • 17. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
    Kanis JA, Johansson H, Oden A, McCloskey EV.
    Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for clinical fractures among postmenopausal women: a 10-year prospective study.
    van Geel TA, Geusens PP, Nagtzaam IF, van der Voort DJ, Schreurs CM, Rinkens PE, Dinant GJ.
    Menopause Int; 2007 Sep; 13(3):110-5. PubMed ID: 17785036
    [Abstract] [Full Text] [Related]

  • 19. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
    Siris ES, Harris ST, Eastell R, Zanchetta JR, Goemaere S, Diez-Perez A, Stock JL, Song J, Qu Y, Kulkarni PM, Siddhanti SR, Wong M, Cummings SR, Continuing Outcomes Relevant to Evista (CORE) Investigators.
    J Bone Miner Res; 2005 Sep; 20(9):1514-24. PubMed ID: 16059623
    [Abstract] [Full Text] [Related]

  • 20. Low dietary riboflavin but not folate predicts increased fracture risk in postmenopausal women homozygous for the MTHFR 677 T allele.
    Yazdanpanah N, Uitterlinden AG, Zillikens MC, Jhamai M, Rivadeneira F, Hofman A, de Jonge R, Lindemans J, Pols HA, van Meurs JB.
    J Bone Miner Res; 2008 Jan; 23(1):86-94. PubMed ID: 17725378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.